Bovine viral diarrhoea virus antigen in foetal calf serum batches and consequences of such contamination for vaccine production

Biologicals

Volumn 31, Issue 3, 2003, Pages 203-208

  Makoschey, B ^a   Gelder, P T J A V ^a   Keijsers, V ^a   Goovaerts, D ^b  

^a INTERVET INTERNATIONAL BV   (Netherlands)

^b MERCK ANIMAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM HYDROXIDE; ALUMINUM PHOSPHATE; VACCINE; VIRUS ANTIGEN;

ANIMAL CELL; ARTICLE; BOVINE DIARRHEA VIRUS; CATTLE; CELL CULTURE; CONTROLLED STUDY; EMBRYO; FETAL CALF SERUM; NONHUMAN; PRIORITY JOURNAL; RNA ANALYSIS; VACCINE PRODUCTION; VIRAL CONTAMINATION; VIRUS INFECTIVITY;

BOS TAURUS; BOVINAE; BOVINE VIRAL DIARRHEA VIRUS 1; PESTIVIRUS;

EID: 0042019987     PISSN: 10451056     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1045-1056(03)00058-7     Document Type: Article

References (28)

1. Froud S.J. The development, benefits and disadvantages of serum-free media. Dev Biol Stand. 99:1999;157-166.
2. Nuttall P.A., Luther P.D., Stott E.J. Viral contamination of bovine foetal serum and cell cultures. Nature. 266:1977;835-837.
3. Moennig V., Liess B. Pathogenesis of intrauterine infections with bovine viral diarrhea virus. Vet Clin North Am Food Anim Pract. 11:1995;477-487.
4. Barkema H.W., Bartels C.J., van Wuijckhuise L., Hesselink J.W., Holzhauer M., Weber M.F., et al. [Outbreak of bovine virus diarrhea on Dutch dairy farms induced by a bovine herpesvirus 1 marker vaccine contaminated with bovine virus diarrhea virus type 2.]. Tijdschr Diergeneeskd. 126:2001;158-165.
5. Falcone E., Tollis M., Conti G. Bovine Viral Diarrhea disease associated with contaminated vaccine. Vaccine. 18:2000;387-388.
6. Kreeft H.A.J.G., Greiser-Wilke I., Moennig V., Horzinek M.C. Attempts to characterize bovine viral diarrhoe virus isolated from cattle after immunization with a contaminated vaccine. Deutsche Tieraerztliche Wochenschrift. 97:1990;63-65.
7. Vannier P., Leforban Y., Carnero R., Cariolet R. Contamination of a live virus vaccine against pseudorabies (Aujeszky's disease) by an ovine pestivirus pathogen for the pig. Ann Rech Vet. 19:1988;283-290.
8. Wensvoort G., Terpstra C. Bovine viral diarrhoea virus infections in piglets born to sows vaccinated against swine fever with contaminated vaccine. Res Vet Sci. 45:1988;143-148.
9. Liess B., Moennig V. Ruminant pestivirus infection in pigs. Rev Sci Tech. 9:1990;151-161.
10. Bolin S.R., Matthews P.J., Ridpath J.F. Methods for detection and frequency of contamination of fetal calf serum with bovine viral diarrhea virus and antibodies against bovine viral diarrhea virus. J Vet Diagn Invest. 3:1991;199-203.
11. Wessman S.J., Levings R.L. Collective experiences of adventitious viruses of animal derived raw materials and what can be done about them. Cytotechnology. 28:1998;43-48.
12. Giangaspero M., Vacirca G., Harasawa R., Buttner M., Panuccio A., De Giuli M.C., et al. Genotypes of pestivirus RNA detected in live virus vaccines for human use. J Vet Med Sci. 63:2001;723-733.
13. Harasawa R. Adventitious pestivirus RNA in live virus vaccines against bovine and swine diseases. Vaccine. 13:1995;100-103.
14. Studer E., Bertoni G., Candrian U. Detection and characterization of pestivirus contaminations in human live viral vaccines. Biologicals. 30:2002;1045-1056.
15. Bolin S.R., Ridpath J.F. Prevalence of bovine viral diarrhea virus genotypes and antibody against those viral genotypes in fetal bovine serum. J Vet Diagn Invest. 10:1998;135-139.
16. The European agency for the evaluation of medicinal products veterinary medicines and inspections. Guideline on requirements and controls applied to bovine serum used in the production of immunological veterinary products. EMEA/CVMP/743/00. 2002.
17. Patel JR, Williams JK. Study towards the selection of a novel broadly antigenic cytopathic BVD virus (cp BVD) strain for inactivation BVDV vaccine Bovilis BVD. Proc XX WAB Congress (6 June 1998) 1998;2:1023.
18. Bolin S.R., Ridpath J.F. Differences in virulence between two noncytopathic bovine viral diarrhea viruses in calves. Am J Vet Res. 53:1992;2157-2163.
19. Makoschey B, Patel JR, Van Gelder PTJA. Serum-free produced bovine Herpesvirus type 1 and bovine parainfluenza type 3 virus vaccines are efficacious and safe. Cytotechnology 2002;39:139-145.
20. Bitsch V., Ronsholt L. Control of bovine viral diarrhea virus infection without vaccines. Vet Clin North Am Food Anim Pract. 11:1995;627-640.
21. Lindberg A.L., Alenius S. Principles for eradication of bovine viral diarrhoea virus (BVDV) infections in cattle populations. Vet Microbiol. 64:1999;197-222.
22. Committee for proprietary medicinal products and committee for veterinary medicinal products. Note for guidance on minimising the risk of transmitting animal spongiform encephalopathy agents via human and veterinary medicinal products. EMEA/410/01. 2001.
23. Detection of cytopathogenic and/or hemadsorbing agents: detection of extraneous agents by the fluorescent antibody technique. Code of Federal Regulations, Parts 113 46 and 113 47, Title 9. 2001.
24. Baker J.C. Bovine viral diarrhea virus: A review. J Am Vet Med Assoc. 190:1987;1449-1458.
25. Brownlie J., Clarke M.C., Howard C.J. Experimental infection of cattle in early pregnancy with a cytopathic strain of bovine virus diarrhoea virus. Res Vet Sci. 46:1989;307-311.
26. Sandvik T., Paton D.J., Lowings P.J. Detection and identification of ruminant and porcine pestiviruses by nested amplification of 5′ untranslated cDNA regions. J Virol Methods. 64:1997;43-56.
27. Vilcek S., Paton D.J., Durkovic B., Strojny L., Ibata G., Moussa A., et al. Bovine viral diarrhoea virus genotype 1 can be separated into at least eleven genetic groups. Arch Virol. 146:2001;99-115.
28. Moennig V., Plagemann P.G. The pestiviruses. Adv Virus Res. 41:1992;53-98.